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Sunday, February 8, 2015 63aoligomerization behavior of tau, it is feasible that loss of foldedness and
increased rigidity of the secondary structure content of soluble protein may
contribute to a loss-of-function and eventually causes cytotoxicity, independent
of intramolecular association.
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In vitro fibrillization of proteins into amyloid fibrils provides critical insights
into the factors influencing protein aggregation and has a key role in under-
standing the molecular basis of several neurodegenerative diseases caused by
amyloids. a-Synuclein (aSyn), an intrinsically disordered protein implicated
in Parkinson’s disease, aggregates readily in vitro into fibrils that exhibit appre-
ciable structural polymorphism. This inherent polymorphism is a major
obstacle in elucidating structural features and understanding the fibrillization
process. By selecting specific solution conditions we were able to produce
morphologically homogeneous fibrils of wt and disease mutant aSyn at the
plateau phase of Thioflavin-T (ThT) assays, as evident from atomic force
microscopy (AFM) imaging and analyses. Our results indicate that the in vitro
aggregation conditions as well as the disease related point mutations of the pro-
tein determine the dominant morphology and the maturation behavior of the
fibrils produced. Specifically, the morphology of wt aSyn fibrils appears to
be dictated by two distinct mechanisms that is competitive growth of different
polymorphs during the fibrillization phase followed by structural rearrange-
ments during the process of aging. In contrast, the disease mutant aSyn variants
aggregate with faster kinetics and result in fibrils with well defined and stable
morphology over time. Additional cross seeding experiments of wt aSyn with
disease mutant proteins have shown faithful transmission of the mutant fibril
morphologies across two generations. The aggregation into homogeneous fibril
populations with mutant-specific morphology is characterized by distinct fibril-
lization kinetics in ThT assays. Moreover, our experiments indicate differential
interaction of ThT with morphologically different aSyn amyloid fibrils.
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The formation of amyloid fibrils of a-synuclein is a pathological hallmark of
the Parkinson’s disease. The fibrillization is an autocatalytic process that is
seeded by mature a-synuclein fibrils. We studied dependence of the fibril
growth rate on the concentrations of monomers and seeds and on mechanical
shaking intensity and proposed a mechanism of a-synuclein aggregation that
includes monomer binding to fibril ends and formation of new growing
centers by fibril breaking. Such an autocatalytic fibrillization mechanism
accounts for distinctive features of the experimentally observed fibrillization
process: - exponential growth of the fibril concentration at the beginning of
(seeded) aggregation - the linear dependence of the observed aggregation
rate constant on the square root of monomer concentration - strong acceleration
of aggregation by shaking. Based on the exponential distribution of
fibril lengths we expect that fibril breaking is random and that the probability
of breaking is proportional to the fibril length. The relatively low efficiency
of the formation of primary fibrils explains the highly stochastic nature of
the observed lag time compared to the aggregation rate. The rate constant of
monomer binding to fibril end could was calculated based on the aggregation
rate and the average length of formed fibrils and corresponds to attachment
of monomer to particular fibril end approximately every 10s. Aggregation rates
at low concentrations show that binding of monomer to the fibril ends is a
reversible process with equilibrium dissociation constant (Kd) less than
3 mM. The proposed model provides a quantitative means to compare a-synu-
clein aggregation rates and affinity to fibril ends under different conditions, and
could be useful in characterizing and designing aggregation inhibitors.
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a-Synuclein (AS) is a intrinsically disordered protein involved in the patho-
genesis of Parkinson’s disease, which is known to form toxic aggregates as
well as fibrils. From a computational point of view, it represents a challengingsystem, as the protein can be found in multiple conformers, separated by
many high free energy barriers. To overcome these barriers, we conducted
replica exchange molecular dynamics. Using the Amber force field in implicit
solvent for the AS monomer, we find transitions between states with both
alpha helix, beta sheet and disordered structure. We also conducted molecular
dynamics simulations for AS fragments to study the propensity for fibril for-
mation. The results will be discussed in the context of existing and recent
experimental findings.
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The aggregation of a-Synuclein (a-Syn) is linked to Parkinson’s disease. The
mechanism of early aggregation steps and the effect of pathogenic single-
point mutations remain elusive. We report here a single molecule fluorescence
study of a-Syn dimerization and the effect of pathological single point muta-
tions. Specific interactions between covalently immobilized fluorophore-free
a-Syn monomers on a substrate and fluorophore-labeled monomers diffusing
freely in solution were observed using total internal reflection fluorescence mi-
croscopy. The results showed that WT a-Syn dimers adopt two types of dimers,
type 1 and type 2. The lifetimes of type 1 and type 2 dimers were determined to
be 1975 3 ms and 33345 145 ms, respectively. All three single point muta-
tions, A30P, E46K and A53T, increased the lifetime of type 1 dimer as well as
enhanced the relative contribution of type 2 dimer in the overall population
with type 1 dimer being the major fraction. The kinetic stability of type 1 di-
mers (expressed in terms of lifetimes) had the following order A30P (693 5
14 ms) > E46K (292 5 5 ms) > A53T (226 5 6 ms) > WT (1975 3 ms).
More stable, type 2 dimers had lifetimes in the range of several seconds. The
strongest effect, observed for the A30P mutant, resulted in a lifetime 3.5 times
higher than WT for type 1 dimer. Moreover, the stability of WT dimers at pH 5
(9385 15 ms) was substantially enhanced compared with that at neutral pH.
Our data suggests that a-Syn dimers are heterogeneous, and single-point muta-
tions and acidic pH promote dimerization as evidenced by longer lifetimes. It
also suggests that heterogeneity of the a-Syn dimerization could give rise to
different aggregation pathways.
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The structures of alpha-synuclein (a-syn) in solutions resemble that of a
random coil because a-syn is one of the intrinsically disordered protein
(IDP). Alpha-syn is of great interest to Parkinson’s researchers because it is
a major constituent of Lewy bodies. Here, we observed characteristic of struc-
tural fluctuation of wild type (WT), phosphorylated mimic (S129E) and famil-
ial mutants (A53T, E46K) by using Diffracted X-ray Tracking (DXT) as x-ray
single molecule detection systems. DXT is a method of measuring internal
motions of the proteins by using trajectories of labeled gold nanocrystal. In
order to measure movements of the specific binding sites of proteins, DXT
monitors of X-ray diffraction spots from gold nanocrystal that were labeled
in the active sites of the proteins. We measured structural fluctuations of in-
dividuala-syn molecules with both high time-resolution (36ms/frame and
0.1ms/frame) and high precision (0.1nm scale). DXT experiments used the en-
ergy of quasi-white x-rays (energy peak-width of 2%, 10-20 keV, BL40XU,
SPring-8). As a result, we discovered that WT’s fluctuation is lower than those
of other mutants (S129E, A53T and E46K) from observed dynamical motion’s
histograms. Furthermore, we found that modes of motions in E46K and A53T
have closer to that of S129E than that of WT. From motion’s histograms in
rotatory direction for the chain axis of a-syn’s amino acid, we confirmed
that motion’s histograms in WT has simple single Gaussian distribution. How-
ever, those in other mutants have complex ones. From our DXT results, it is
very clear that there is specific different motions between WT of a-syn and
other mutants. In addition to, we found that there is different number of
X-ray diffraction spots from gold nanocrystal between WT of a-syn and other
mutants.
